STR Release
Natural health product licensed in Canada
- Other names
- Mysiah Health - STR
- Licence holder
- biOMics LLC
- NPN or DIN-HM
- 80118257
- Status
- Active licence
- Licence date
- 2 May 2022
- Revision date
- 18 June 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Aphanizomenon flos-aquae Ralfs ex Bornet & Flahault: Les préparations de cette plante sont seulement autorisées s'il peut être démontré par des rapports d'analyse qu'elles ne contiennent pas de microcystine (< 1µg/g) et d'autres toxines marines.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hippophae rhamnoides Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,500 mg | 250 mg | Not calculated |
| Fucus vesiculosus Source : En entier Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 1,000 mg | 125 mg | Not calculated |
| bêta-1,3/1,6-glucane Source : Saccharomyces cerevisiae - Écorce de levure | 50 mg | Not calculated |
| Aphanizomenon flos-aquae Source : En entier Extract : Matériel brut sec Extraction ratio : 3.333:1 Dry plant equivalent : 500 mg | 150 mg | Not calculated |
| Panax notoginseng Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 625 mg | 62.5 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Fucus vesiculosus is Traditionally used in Herbal Medicine as an alterative for the glandular system. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Used in Herbal Medicine to support normal thyroid function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80118257
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.